GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
45.35 +0.21  +0.47% NYSE Oct 31, 3:26PM BATS Real time Currency in USD

GlaxoSmithKline Cash from Investing (TTM):

1.674B for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Investing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Investing (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 1.674B
June 30, 2014 1.202B
March 31, 2014 729.75M
Dec. 31, 2013 819.61M
Sept. 30, 2013 -2.430B
June 30, 2013 -5.407B
March 31, 2013 -4.858B
Dec. 31, 2012 -4.169B
Sept. 30, 2012 -4.506B
June 30, 2012 -1.084B
March 31, 2012 -1.289B
Dec. 31, 2011 -179.51M
Sept. 30, 2011 -280.69M
June 30, 2011 -691.25M
March 31, 2011 -1.044B
Dec. 31, 2010 -2.885B
Sept. 30, 2010 -2.884B
June 30, 2010 -6.109B
March 31, 2010 -5.811B
Dec. 31, 2009 -6.263B
Sept. 30, 2009 -6.820B
June 30, 2009 -3.224B
March 31, 2009 -2.569B
Dec. 31, 2008 -2.106B
Sept. 30, 2008 -3.432B
   
June 30, 2008 -3.766B
March 31, 2008 -4.594B
Dec. 31, 2007 -6.027B
Sept. 30, 2007 -4.562B
June 30, 2007 -4.677B
March 31, 2007 -4.431B
Dec. 31, 2006 -2.800B
Sept. 30, 2006 -3.807B
June 30, 2006 -3.364B
March 31, 2006 -3.426B
Dec. 31, 2005 -3.017B
Sept. 30, 2005 -1.044B
June 30, 2005 -1.374B
March 31, 2005 -1.306B
Dec. 31, 2004 -1.685B
Sept. 30, 2004 -2.087B
June 30, 2004 -1.697B
March 31, 2004 -1.571B
Dec. 31, 2003 -1.533B
Sept. 30, 2003 -1.597B
June 30, 2003 -1.605B
March 31, 2003 -1.694B
Dec. 31, 2002 -1.711B
Sept. 30, 2002 -2.324B
June 30, 2002 -2.707B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

GSK Cash from Investing (TTM) Benchmarks

Companies
AstraZeneca -6.606B
Johnson & Johnson -10.96B
Pfizer -2.147B

GSK Cash from Investing (TTM) Range, Past 5 Years

Minimum -6.263B Dec 2009
Maximum 1.674B Sep 2014
Average -2.273B

GSK Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("GSK", "cash_investing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.